Equol as a Multitarget Agent Against Neurodegeneration: Mechanistic Insights into Its Molecular Modulation

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Neurodegenerative diseases are progressive neuronal disorders with rising global impact.
• Pathophysiology involves oxidative stress, neuroinflammation, nitrosative stress, and apoptosis.
• Current treatments offer symptomatic relief, necessitating novel therapeutic strategies targeting multiple mechanisms.

Purpose of the Study:

• To review the mechanistic pathways through which equol confers neuroprotection.
• To explore equol's potential as a therapeutic agent for neurodegenerative diseases.
• To highlight equol's ability to modulate key molecular targets involved in neurodegeneration.

Main Methods:

• Literature review of studies on equol and neuroprotection.
• Analysis of equol's modulation of signaling pathways (e.g., TLR-4/MAPK/NF-κB, NLRP3 inflammasome).
• Examination of equol's effects on oxidative stress (ROS), neuroinflammation, and apoptosis.

Main Results:

• Equol modulates key mediators including TLR-4, MAPKs, NLRP3 inflammasome, ROS, and inflammatory mediators.
• Equol demonstrates neuroprotective effects by targeting multiple pathological pathways.
• Reduced estrogen receptor expression exacerbates neurodegeneration, a factor potentially influenced by equol.

Conclusions:

• Equol exhibits significant potential in combating neurodegeneration through multi-target modulation.
• Further research into equol's therapeutic applications for neurodegenerative diseases is warranted.
• Equol represents a promising phytomolecule for addressing the complex pathophysiology of neurodegeneration.